124 related articles for article (PubMed ID: 9222280)
1. Synergistic effects of Actinobacillus suis cells in combination with 5-fluorouracil on mice bearing murine L1210 leukemia cells.
Watanabe T; Itoh S
Cancer Immunol Immunother; 1997 Jun; 44(4):216-20. PubMed ID: 9222280
[TBL] [Abstract][Full Text] [Related]
2. Schedule-dependent antitumor activity and toxicity of combinations of 5-fluorouracil and cisplatin/carboplatin against L1210 leukemia-bearing mice.
Fujimoto S
Biol Pharm Bull; 2006 Nov; 29(11):2260-6. PubMed ID: 17077525
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of antileukemic effect in combination of 5-fluorouracil and OK-432.
Koshimura S; Ryoyama K
Cancer Treat Rep; 1977; 61(1):17-27. PubMed ID: 324619
[TBL] [Abstract][Full Text] [Related]
4. Enhanced cytotoxic interaction between 5-fluorouracil and 4-hydroperoxycyclophosphamide against L1210 murine leukemic cells: applicability to ex vivo purging.
Mao XY; Higashigawa M; M'Soka T; Shimono Y; Nagata T; Inamochi H; Cao DC; Hori H; Kawasaki H; Sakurai M
Cancer Invest; 1999; 17(7):486-93. PubMed ID: 10518193
[TBL] [Abstract][Full Text] [Related]
5. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
Ujiie T
Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200
[TBL] [Abstract][Full Text] [Related]
6. Potentiatied antitumor effectiveness of combined chemo-immunotherapy with interleukin-12 and 5-fluorouracil of L1210 leukemia in vivo.
Goł b J; Zagozdzon R; Kamiński R; Kozar K; Gryska K; Izycki D; Mackiewicz A; Stokłosa T; Giermasz A; Lasek W; Jakóbisiak M
Leukemia; 2001 Apr; 15(4):613-20. PubMed ID: 11368364
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapeutic response of concanavalin A-bound L1210 vaccine enhanced by a streptococcal immunopotentiator, OK-432.
Kataoka T; Oh-hashi F; Sakurai Y
Cancer Res; 1979 Jul; 39(7 Pt 1):2807-10. PubMed ID: 445486
[TBL] [Abstract][Full Text] [Related]
9. Successful chemoimmunotherapy of murine L1210 lymphatic leukemia with cyclophosphamide and mafosfamide-treated leukemia cells.
Kawalec M; Skórski T; Kawiak J
Invest New Drugs; 1988 Sep; 6(3):169-72. PubMed ID: 3192382
[TBL] [Abstract][Full Text] [Related]
10. Induction of transplantation resistance to murine L1210 leukemia cells in BCG-primed mice by immunization with tuberculin protein-coupled L1210 cells.
Ohno R; Kodera Y; Ogura M; Yamada H
Gan; 1984 Feb; 75(2):187-92. PubMed ID: 6428959
[TBL] [Abstract][Full Text] [Related]
11. Effect of OK-432 on immunization with mitomycin-C-treated L1210 cells.
Ryoyama K; Murayama T; Koshimura S
Gan; 1979 Feb; 70(1):75-82. PubMed ID: 376388
[TBL] [Abstract][Full Text] [Related]
12. Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in mice.
Warzocha K; Robak T
Acta Haematol Pol; 1992; 23(1):55-62. PubMed ID: 1615753
[TBL] [Abstract][Full Text] [Related]
13. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
Góra-Tybor J; Robak T; Warzocha K; Grieb P
Arch Immunol Ther Exp (Warsz); 1994; 42(1):39-42. PubMed ID: 7503633
[TBL] [Abstract][Full Text] [Related]
14. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
Góra-Tybor J; Robak T
Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
[TBL] [Abstract][Full Text] [Related]
15. Differential selectivity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in cultured human B lymphocytes and mouse L1210 leukemia.
Au JL; Rustum YM; Minowada J; Srivastava BI
Biochem Pharmacol; 1983 Feb; 32(3):541-6. PubMed ID: 6221728
[TBL] [Abstract][Full Text] [Related]
16. Combination of dihydroxyanthraquinone and radiation on L1210 murine leukemia.
Kimler BF; Hacker MP
Cancer Clin Trials; 1981; 4(2):173-6. PubMed ID: 7249253
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of the efficacy of murine L1210 leukemia vaccine by a novel immunostimulator 7-thia-8-oxoguanosine: increased survival after immunization with vaccine plus 7-thia-8-oxoguanosine.
Sharma BS; Balazs L; Jin A; Wang JC; Jolley WB; Robins RK
Cancer Immunol Immunother; 1991; 33(2):109-14. PubMed ID: 2036658
[TBL] [Abstract][Full Text] [Related]
18. Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin.
Zagozdzon R; Gołab J; Stokłosa T; Giermasz A; Nowicka D; Feleszko W; Lasek W; Jakóbisiak M
Int J Cancer; 1998 Aug; 77(5):720-7. PubMed ID: 9688305
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effectiveness of neuraminidase-treated tumor cells as an immunogen in man and experimental animals with leukemia.
Bekesi JG; Roboz JP; Holland JF
Ann N Y Acad Sci; 1976; 277(00):313-31. PubMed ID: 1069551
[TBL] [Abstract][Full Text] [Related]
20. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
Nitta K; Tanaka T; Takeuchi M
Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
